Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
The origin of tumor heterogeneity is poorly understood, yet it represents a major barrier to effective therapy. In melanoma and in melanocyte development, the microphthalmia-associated transcription factor (Mitf) controls survival, differentiation, proliferation, and migration/metastasis. The Brn-2...
المؤلفون الرئيسيون: | Goodall, J, Carreira, S, Denat, L, Kobi, D, Davidson, I, Nuciforo, P, Sturm, R, Larue, L, Goding, C |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2008
|
مواد مشابهة
-
The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes.
حسب: Carreira, S, وآخرون
منشور في: (2000) -
The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
حسب: Schepsky, A, وآخرون
منشور في: (2006) -
CBP/p300 as a co-factor for the Microphthalmia transcription factor.
حسب: Sato, S, وآخرون
منشور في: (1997) -
The Brn-2 transcription factor links activated BRAF to melanoma proliferation.
حسب: Goodall, J, وآخرون
منشور في: (2004) -
The role of the transcription factor BRN2 in melanoma
حسب: Herbert, K
منشور في: (2018)